IGF1 and carcinoma: We assessed the expression of 18 partners associated with the IGF signaling pathway, including receptors, IGFBPs, Akt, PI3K and Erk isoforms, by quantitative RT-PCR in 10 IGF2-low and the 23 IGF2-high carcinoma.